November 25, 2016 - By kentuckypostne · 0 Comments
The stock of Biotelemetry Incorporated (NASDAQ:BEAT) registered an increase of 12.69% in short interest. BEAT’s total short interest was 831,800 shares in November as published by FINRA. Its up 12.69% from 738,100 shares, reported previously. With 221,400 shares average volume, it will take short sellers 4 days to cover their BEAT’s short positions. The short interest to Biotelemetry Incorporated’s float is 3.03%. About 75,503 shares traded hands. BioTelemetry, Inc. (NASDAQ:BEAT) has risen 63.43% since April 22, 2016 and is uptrending. It has outperformed by 58.02% the S&P500.
Insitutional Activity: The institutional sentiment decreased to 1.39 in Q2 2016. Its down 0.09, from 1.48 in 2016Q1. The ratio fall, as 7 funds sold all BioTelemetry, Inc. shares owned while 43 reduced positions. 35 funds bought stakes while 39 increased positions. They now own 20.72 million shares or 1.56% less from 21.05 million shares in 2016Q1.
New York State Common Retirement Fund holds 210,465 shares or 0.01% of its portfolio. Thompson Siegel & Walmsley Limited Company accumulated 1.03M shares or 0.26% of the stock. The Illinois-based Gru One Trading L P has invested 0% in BioTelemetry, Inc. (NASDAQ:BEAT). Teton Advsr Incorporated has 0.21% invested in the company for 145,100 shares. Fortaleza Asset Inc reported 10,915 shares or 0.15% of all its holdings. Goldman Sachs Grp Incorporated last reported 11,545 shares in the company. Moreover, Kalmar Invs Incorporated De has 0.28% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 389,173 shares. Citigroup reported 3,213 shares or 0% of all its holdings. Panagora Asset last reported 250,503 shares in the company. First Quadrant L P Ca, a California-based fund reported 12,200 shares. Moreover, Retail Bank Of Ny Mellon has 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 237,427 shares. Moreover, First Light Asset Management Ltd Limited Liability Company has 1.93% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 255,163 shares. Susquehanna Grp Llp holds 0% or 69,760 shares in its portfolio. Moreover, Allianz Asset Mngmt Ag has 0.01% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 568,063 shares. Moreover, Walleye Trading Limited Liability has 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 600 shares.
Out of 2 analysts covering BioTelemetry (NASDAQ:BEAT), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. BioTelemetry has been the topic of 2 analyst reports since July 28, 2015 according to StockzIntelligence Inc. The stock has “Buy” rating given by Dougherty & Company on Tuesday, July 28. As per Tuesday, September 13, the company rating was initiated by Sidoti.
BioTelemetry, Inc. (BioTelemetry), incorporated on April 12, 2013, provides cardiac monitoring services, cardiac monitoring device manufacturing and cardiac laboratory services. The Firm operates through three divisions: Healthcare, Technology and Research. The Company’s subsidiary is CardioNet, Inc.
More notable recent BioTelemetry, Inc. (NASDAQ:BEAT) news were published by: Globenewswire.com which released: “BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the …” on July 26, 2016, also Marketwatch.com with their article: “/quotes/zigman/3870025/realtime” published on December 21, 2009, Globenewswire.com published: “BioTelemetry, Inc. Agrees to License Proprietary Technology to Bloom …” on August 23, 2016. More interesting news about BioTelemetry, Inc. (NASDAQ:BEAT) were released by: Fool.com and their article: “Here’s Why BioTelemetry, Inc. Is Soaring Today” published on October 05, 2016 as well as Globenewswire.com‘s news article titled: “BioTelemetry, Inc. Announces the Completion of Its Acquisition of …” with publication date: May 11, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.